Crossmark

An oncolytic herpes simplex virus type 1 strain expressing a single-chain variable region antibody fragment against PD-1 and a PI3K inhibitor synergize to elicit antitumor immunity in ovarian cancer

Crossref DOI link: https://doi.org/10.1007/s00705-023-05754-1

Published Online: 2023-03-31

Published Print: 2023-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Huang, Shanying https://orcid.org/0000-0003-3158-6959
Hu, Haiyan

Tang, Guoling

Liu, Kai

Luo, Zhihua

Zeng, Weiwei
Funding

Funding for this research was provided by:

Medical Science and Technology Research Fund project of Guangdong Province (B2021289)
License Information

Text and Data Mining valid from 2023-03-31

Version of Record valid from 2023-03-31
More Information

Article History

Received: 15 September 2022

Accepted: 21 February 2023

First Online: 31 March 2023

Declarations

:

: The authors have no relevant financial or nonfinancial interests to disclose.

Document is current

Any future updates will be listed below